The First SmartMS-Enabled Biopharma Solution
Engineered Simplicity
The BioAccord LC-MS System is the first SmartMS-enabled biopharmaceutical solution. This compact, self-optimizing system has a built-in health check that ensures the system is always generating data of the required quality.
The simplicity provided by SmartMS means that the BioAccord generates the same high-quality results whether you are an LC-MS expert or a new user.
Robust and Reproducible
Rigorous validation of the complete solution has been implemented during the development and manufacture of the system with extended testing across multiple systems. The tests comprise complete biopharmaceutical methods, from sample to reported result, with application-relevant acceptance criteria that meet biopharmaceutical industry standards.
The BioAccord LC-MS System is operating in academic, biopharmaceutical and contract laboratories worldwide, generating consistent and reproducible results every day
Addressing Your Applications
Whether your work involves analyzing biomolecules at the intact, subunit, peptide, or released glycan level, the BioAccord System comes with optimized compliance-ready workflows so you can get up and running right away. These include:
- Intact mass analysis of proteins and oligonucleotides
- Subunit analysis of monoclonal antibodies (mAbs)
- Peptide mapping/MAM (multi-attribute method)
- Released N-glycan analysis
Compliance
Although the system can be used easily in research and early development environments, it has all the tools for adoption by the demanding regulatory environments of late development and QC.
With a complete audit trail, configurable access controls and the protection of an Oracle database this system has everything you need to ensure data integrity and meet 21 CFR part 11 and Annex 11 requirements.